American Tegumentary Leishmaniasis

[1]  A. Siqueira,et al.  American tegumentary leishmaniasis and HIV-AIDS association in a tertiary care center in the Brazilian Amazon. , 2011, The American journal of tropical medicine and hygiene.

[2]  M. Teixeira,et al.  Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response. , 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  Olga Laura Sena Almeida,et al.  Avanços no tratamento da leishmaniose tegumentar do novo mundo nos últimos dez anos: uma revisão sistemática da literatura , 2011 .

[4]  H. Silveira,et al.  Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon , 2011, PLoS neglected tropical diseases.

[5]  R. Dietze,et al.  Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil. , 2011, The American journal of tropical medicine and hygiene.

[6]  J. Ampuero,et al.  Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial , 2010, PLoS neglected tropical diseases.

[7]  N. Craft,et al.  Human Immunodeficiency Virus and Leishmaniasis , 2010, Journal of global infectious diseases.

[8]  R. Dietze,et al.  Tegumentary leishmaniasis as the cause of immune reconstitution inflammatory syndrome in a patient co-infected with human immunodeficiency virus and Leishmania guyanensis. , 2009, The American journal of tropical medicine and hygiene.

[9]  P. Machado,et al.  Recruitment of CD8+ T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis , 2009, Parasite immunology.

[10]  H. Bang,et al.  Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  A. Giudice,et al.  Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production , 2006, BMC infectious diseases.

[12]  E. Carvalho,et al.  Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. , 2005, Immunology letters.

[13]  J. Berman,et al.  Advances in leishmaniasis , 2005, The Lancet.

[14]  P. Couppié,et al.  Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)‐infected patients and non‐HIV‐infected patients in French Guiana , 2004 .

[15]  P. Desjeux.  Leishmaniasis: current situation and new perspectives. , 2004, Comparative immunology, microbiology and infectious diseases.

[16]  R. Pradinaud,et al.  Leishmania and HIV co-infection: dermatological manifestations , 2003, Annals of tropical medicine and parasitology.

[17]  E. Carvalho,et al.  Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. , 2002, The Journal of infectious diseases.

[18]  P. Machado,et al.  Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis Patients , 2002, Infection and Immunity.

[19]  E. Carvalho,et al.  Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. , 1994, Acta tropica.

[20]  E. Fikrig,et al.  Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. , 1987, The Journal of infectious diseases.

[21]  E. Carvalho,et al.  Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. , 1986, The Journal of tropical medicine and hygiene.

[22]  E. Carvalho,et al.  Cytokine profile and pathology in human leishmaniasis. , 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[23]  P. Machado,et al.  Human cutaneous leishmaniasis: recent advances in physiopathology and treatment , 1995 .

[24]  J. Convit,et al.  Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. , 1972, Transactions of the Royal Society of Tropical Medicine and Hygiene.